The Centre has released guidelines for Covid-19 vaccination of children between 12-14 years that will begin from March 16 and said only Corbevax vaccine would be used for the beneficiaries of this age group.

Two doses of Biological E's intramuscular vaccine Corbevax would be administered to the beneficiaries in the 12-14 years age group at an interval of 28 days, the guidelines said. The Centre shared also these guidelines with states in a letter issued on Monday. Covid-19 vaccination of children between 12-14 years will begin from March 16 and only Corbevax vaccine would be used for the beneficiaries of age group 12-13 and 13-14 years, it said.